At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 426 enrolled
Drug / intervention
LEO 90100 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
In Brief
A Phase 3 clinical trial evaluating LEO 90100 and Vehicle for Psoriasis Vulgaris. Completed, enrolled 426 participants across 1 site.
Detailed Summary
The purpose of this trial is to compare the efficacy of treatment with LEO 90100 to that of treatment with vehicle for up to 4 weeks in subjects with psoriasis vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 2013
Enrollment StartJun 2013
Primary CompletionOct 2013
Study CompletionNov 2013
TodayJul 2026
First PostedMay 31, 2013
Enrollment StartJun 1, 2013
Primary CompletionOct 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.1 years ago
Interventions
LEO 90100drug
Vehicledrug